| The consensus molecular subtypes of colorectal cancer J Guinney, R Dienstmann, X Wang, A De Reynies, A Schlicker, ... Nature medicine 21 (11), 1350-1356, 2015 | 3772 | 2015 |
| Gene expression signature to improve prognosis prediction of stage II and III colorectal cancer R Salazar, P Roepman, G Capella, V Moreno, I Simon, C Dreezen, ... J clin oncol 29 (1), 17-24, 2011 | 620 | 2011 |
| Pan-cancer whole-genome analyses of metastatic solid tumours P Priestley, J Baber, MP Lolkema, N Steeghs, E de Bruijn, C Shale, ... Nature 575 (7781), 210-216, 2019 | 577 | 2019 |
| An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas P Roepman, LFA Wessels, N Kettelarij, P Kemmeren, AJ Miles, ... Nature genetics 37 (2), 182-186, 2005 | 504 | 2005 |
| MED12 controls the response to multiple cancer drugs through regulation of TGF-β receptor signaling S Huang, M Hölzel, T Knijnenburg, A Schlicker, P Roepman, U McDermott, ... Cell 151 (5), 937-950, 2012 | 446 | 2012 |
| Colorectal cancer intrinsic subtypes predict chemotherapy benefit, deficient mismatch repair and epithelial‐to‐mesenchymal transition P Roepman, A Schlicker, J Tabernero, I Majewski, S Tian, V Moreno, ... International journal of cancer 134 (3), 552-562, 2014 | 361 | 2014 |
| An immune response enriched 72-gene prognostic profile for early-stage non–small-cell lung cancer P Roepman, J Jassem, EF Smit, T Muley, J Niklinski, T van de Velde, ... Clinical Cancer Research 15 (1), 284-290, 2009 | 171 | 2009 |
| The MK5/PRAK kinase and Myc form a negative feedback loop that is disrupted during colorectal tumorigenesis TR Kress, IG Cannell, AB Brenkman, B Samans, M Gaestel, P Roepman, ... Molecular cell 41 (4), 445-457, 2011 | 169 | 2011 |
| Integrated assessment by multiple gene expression analysis of quercetin bioactivity on anticancer–related mechanisms in colon cancer cells in vitro MJ van Erk, P Roepman, TR van der Lende, RH Stierum, J Aarts, ... European journal of nutrition 44 (3), 143-156, 2005 | 163 | 2005 |
| A diagnostic gene profile for molecular subtyping of breast cancer associated with treatment response O Krijgsman, P Roepman, W Zwart, JS Carroll, S Tian, FA de Snoo, ... Breast cancer research and treatment 133, 37-47, 2012 | 151 | 2012 |
| The Drug Rediscovery protocol facilitates the expanded use of existing anticancer drugs DL van der Velden, LR Hoes, H Van Der Wijngaart, ... Nature 574 (7776), 127-131, 2019 | 148 | 2019 |
| A combined oncogenic pathway signature of BRAF, KRAS and PI3KCA mutation improves colorectal cancer classification and cetuximab treatment prediction S Tian, I Simon, V Moreno, P Roepman, J Tabernero, M Snel, L van't Veer, ... Gut, 2012 | 144 | 2012 |
| Independent Validation of a Prognostic Genomic Signature (ColoPrint) for Patients With Stage II Colon Cancer M Maak, I Simon, U Nitsche, P Roepman, M Snel, AM Glas, T Schuster, ... Annals of Surgery, 2013 | 143 | 2013 |
| Biological functions of the genes in the mammaprint breast cancer profile reflect the hallmarks of cancer S Tian, P Roepman, LJ Van't Veer, R Bernards, F De Snoo, AM Glas Biomarker insights 5, BMI. S6184, 2010 | 143 | 2010 |
| Identification of recurrent FGFR3 fusion genes in lung cancer through kinome‐centred RNA sequencing IJ Majewski, L Mittempergher, NM Davidson, A Bosma, SM Willems, ... The Journal of pathology 230 (3), 270-276, 2013 | 141 | 2013 |
| Integration of gene dosage and gene expression in non-small cell lung cancer, identification of HSP90 as potential target MI Gallegos Ruiz, K Floor, P Roepman, JA Rodriguez, GA Meijer, ... PloS one 3 (3), e0001722, 2008 | 140 | 2008 |
| The NuRD complex cooperates with DNMTs to maintain silencing of key colorectal tumor suppressor genes Y Cai, EJ Geutjes, K De Lint, P Roepman, L Bruurs, LR Yu, W Wang, ... Oncogene 33 (17), 2157-2168, 2014 | 127 | 2014 |
| MammaPrint molecular diagnostics on formalin-fixed, paraffin-embedded tissue A Sapino, P Roepman, SC Linn, MHJ Snel, LJMJ Delahaye, ... The Journal of Molecular Diagnostics 16 (2), 190-197, 2014 | 115 | 2014 |
| Microarray-Based Determination of Estrogen Receptor, Progesterone Receptor, and HER2 Receptor Status in Breast CancerMicroarray Readout of ER, PR, and HER2 P Roepman, HM Horlings, O Krijgsman, M Kok, JM Bueno-de-Mesquita, ... Clinical Cancer Research 15 (22), 7003-7011, 2009 | 113 | 2009 |
| Multiple robust signatures for detecting lymph node metastasis in head and neck cancer P Roepman, P Kemmeren, LFA Wessels, PJ Slootweg, FCP Holstege Cancer Research 66 (4), 2361-2366, 2006 | 100 | 2006 |
Rene BernardsNetherlands Cancer InstituteVerified email at nki.nl
